Details for: CL0000986

Cell ID: CL0000986

Cell Name: IgM plasma cell

Description: A fully differentiated plasma cell that secretes IgM.

Selected Context(s): Overall

Gene Significance Landscape

Display Options
Score:
Display
Genes

Contexts:

Cell Significance Index (CSI) is uniquely calculated to reveal cell-specific gene markers. More info here

Significant Genes List

Genes with the highest and lowest Percentile Rank Scores (PRS) for IgM plasma cell within the selected context(s).

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for IgM plasma cell. Higher scores indicate a stronger, more significant difference in expression.
(Previously described as "Fold Change", but now represents Cliff's Delta × –log10(p).)

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for IgM plasma cell. Higher scores indicate a stronger, more significant difference in expression.
Average CSI: csi sum / gene count
Cell network configuration

This network visualizes key genes for IgM plasma cell. It primarily includes:
1. Top genes highly significant for this cell (Num. Top Cell Genes - based on the 'Min. CSI' setting).
2. Any additional specific 'Context Genes' you add below.
The final network is a combined view. Choose an Interaction Source (pathways or protein interactions) and optionally compare CSI scores with a Baseline Cell Type.

Maximum number of selected genes.
Select a context for the baseline cell.
Select a context for the target cell.
Target Cell for CSI:  IgM plasma cell (CL0000986)

 Legend
Nodes (Genes):
 Query Gene
Node size also reflects Target Cell CSI magnitude.
Node Color (Target Cell CSI in specific network):
 Very High
 High
 Medium
 Low
 Very Low
 N/A or Not Sig.
Edges (Interactions):
 STRING (Protein-Protein)
 ONTOLOGY (Shared Pathway)
 Colors vary by pathway category; default arrow applies.

Loading network (please wait)...

## Summary The [IgM plasma cell](/details-cell/CL0000986) is a terminally differentiated B-lymphocyte whose primary function is the large-scale production and secretion of Immunoglobulin M (IgM). Analysis of its gene significance profile reveals an identity overwhelmingly defined by the cellular machinery required for this immense biosynthetic task. The top markers are not immunoglobulin genes themselves, but rather a suite of genes involved in high-level protein synthesis, folding, and energy production. The expression landscape, characterized by high specificity scores (`csi_z`) for genes related to mitochondrial respiration and endoplasmic reticulum function, portrays this cell as a highly specialized protein factory, optimized for mass production at the cost of other lymphoid functions like antigen presentation. ## Key Characteristics and Function The functional identity of the [IgM plasma cell](/details-cell/CL0000986) is dominated by two core biological themes: massive energy production and a robust protein synthesis/secretion pipeline. * **High Metabolic Activity and Energy Production:** The most prominent feature of this cell's expression profile is the specific enrichment of genes encoding components of the mitochondrial electron transport chain. A large number of these genes, including [COX1](/details-gene/4512), [ND2](/details-gene/4536), [COX2](/details-gene/4513), [ND4](/details-gene/4538), and [CYTB](/details-gene/4519), show high `csi_z` scores. This suggests that an extremely high rate of aerobic respiration is a defining characteristic, necessary to generate the vast amounts of ATP required to fuel the synthesis of large pentameric IgM antibodies. Genes such as [ATP5MG](/details-gene/10632) and [SLC25A6](/details-gene/293) further underscore the cell's reliance on mitochondrial ATP production and transport. * **Protein Synthesis and Quality Control:** Consistent with its role as a professional secretory cell, the [IgM plasma cell](/details-cell/CL0000986) is distinguished by high expression of genes essential for protein translation, folding, and processing. Key markers include translation elongation factors ([EEF1D](/details-gene/1936), [EEF1B2](/details-gene/1933)) and components of the endoplasmic reticulum (ER). The high significance of [HERPUD1](/details-gene/9709), a gene induced by ER stress ([Link](https://doi.org/10.1074/jbc.m002063200)), indicates that the cell operates under a constant state of high protein-folding load, activating the unfolded protein response (UPR) as a homeostatic mechanism. Furthermore, [OST4](/details-gene/100128731), a subunit of the oligosaccharyltransferase complex required for N-linked glycosylation ([Link](https://doi.org/10.1242/jcs.115410)), highlights the importance of post-translational modifications for secreted IgM. The top marker, [B2M](/details-gene/567), while a component of MHC class I, is also a critical indicator of high protein turnover and cellular metabolism. * **Terminal Differentiation Signature:** The anti-marker profile strongly confirms the cell's terminally differentiated state. The lack of significant expression for key B-cell identity genes such as [CD79A](/details-cell/973) (a B-cell receptor component) and genes involved in antigen presentation like [HLA-DRB5](/details-gene/3127) (MHC Class II) and [TAP1](/details-gene/6890) indicates a shutdown of the cellular programs for antigen recognition and presentation to T-cells. This allows the cell to dedicate its resources exclusively to antibody secretion. ## Clinical Significance and Contextual Roles **Overall**, the gene signature of the [IgM plasma cell](/details-cell/CL0000986) has significant implications for both normal immune responses and hematological malignancies. As the primary source of IgM, these cells are crucial in the early phase of humoral immunity against pathogens. The cell's defining characteristic—a state of high metabolic and ER stress—is also a key vulnerability exploited in plasma cell dyscrasias like multiple myeloma and Waldenström's macroglobulinemia (an IgM-secreting malignancy). The elevated expression of genes like [HERPUD1](/details-gene/9709) and the reliance on the proteasome system (indicated by markers like [UBB](/details-gene/7314)) are hallmarks of malignant plasma cells. Consequently, therapies targeting the proteasome or other components of the protein quality control system are effective treatments for these diseases. The profound dependence on mitochondrial energy production suggests that targeting cellular metabolism could be another viable therapeutic avenue for controlling pathological plasma cell proliferation. ## Potential Mechanisms and Research Directions 1. **Hypothesis:** The defining characteristic of an [IgM plasma cell](/details-cell/CL0000986) is not merely the expression of IgM, but its adaptation to a state of chronic, high-level ER and metabolic stress, making it uniquely susceptible to perturbations in protein folding and energy pathways. * **Surprising Findings:** The most specific gene markers are not the immunoglobulin chains but rather the supportive "factory" machinery. The top-ranked gene, [B2M](/details-gene/567), is part of the MHC-I complex but likely serves here as a proxy for the immense protein turnover and secretory pathway load, a less-appreciated role for this molecule in this context. * **Testable Questions:** To what extent does inhibiting specific UPR branches (e.g., IRE1 or PERK) selectively impair IgM secretion and viability in [IgM plasma cells](/details-cell/CL0000986) versus other secretory cell types? Can mitochondrial inhibitors be used to modulate the IgM response during an active infection? 2. **Hypothesis:** The downregulation of B-cell receptor ([CD79A](/details-gene/973)) and antigen presentation ([HLA-DRB5](/details-gene/3127)) machinery is an active, irreversible process that serves as a commitment to terminal differentiation, effectively insulating the cell from further antigenic stimulation to ensure stable, high-level antibody output. * **Surprising Findings:** The data reveal a clear and mutual exclusivity between the machinery for antibody production and the machinery for antigen sensing/presentation. This suggests a tightly regulated genetic switch, where the upregulation of one program actively suppresses the other. * **Testable Questions:** What are the key transcription factors that orchestrate the simultaneous upregulation of secretory pathway genes (e.g., [HERPUD1](/details-gene/9709)) and downregulation of B-cell identity genes ([CD79A](/details-gene/973)) during plasma cell differentiation? Does aberrant re-expression of these "anti-markers" in plasma cell malignancies correlate with de-differentiation or altered clinical outcomes?